Sanctions Against Anti-Israel UN Official Go Into Effect
Federal Judges Just Ruled on Biden's Request to Conceal Ghostwriter Tapes
This Is Why You Should Never Leave Joe Biden Alone on a Stage
US Media Entirely Ignore British Rape Gangs Report; Abby Phillip Is Unwound by...
Italy's Prime Minister Is Not Happy With President Trump
USDA Uncovers Hundreds of Thousands of SNAP Fraud Cases as Blue States Continue...
Zohran Mamdani Just Set the Tone for the Democratic Party’s Future
Ninth Circuit Grants Preliminary Injunction Blocking CA Law Hiding Kids' Gender Identity F...
Jury Convicts Tahoe Man in $1M Crypto Fraud Scheme
Texas Brothers Plead Guilty to $8 Million Crypto Kidnapping in Minnesota
Illegal Alien from Chile Sentenced to 45 Months for Multi-State Identity Theft Scheme
U.S. Destroys Australia 2-0 to Secure Spot in World Cup Knockout Rounds
Michigan Man Pleads Guilty to $2.7 Million Investment Fraud Scheme
John Cornyn Continues His Curiously Militant Opposition to the SAVE Act
DOJ Launches Investigation Into Major League Baseball for Targeting of Christians
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement